WT
TAK icon

Whittier Trust’s Takeda Pharmaceutical TAK Stock Holding History

Whittier Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70
Closed -$998 – 1560
2023
Q4 		$998 Hold
70
– – ﹤0.01% 1445
2023
Q3 		$1.08K Sell
70
-50
-42% -$774 ﹤0.01% 1510
2023
Q2 		$1.88K Sell
120
-30
-20% -$492 ﹤0.01% 1452
2023
Q1 		$2.47K Sell
150
-150
-50% -$2.39K ﹤0.01% 1468
2022
Q4 		$4.68K Sell
300
-30
-9% -$419 ﹤0.01% 1393
2022
Q3 		$5K Sell
330
-30
-8% -$417 ﹤0.01% 1453
2022
Q2 		$5K Sell
360
-260
-42% -$3.71K ﹤0.01% 1453
2022
Q1 		$9K Sell
620
-12
-2% -$176 ﹤0.01% 1361
2021
Q4 		$9K Hold
632
– – ﹤0.01% 1332
2021
Q3 		$10K Hold
632
– – ﹤0.01% 1250
2021
Q2 		$11K Hold
632
– – ﹤0.01% 1260
2021
Q1 		$12K Buy
632
+80
+14% +$1.44K ﹤0.01% 1231
2020
Q4 		$10K Sell
552
-110
-17% -$1.93K ﹤0.01% 1155
2020
Q3 		$12K Sell
662
-399
-38% -$7.26K ﹤0.01% 1103
2020
Q2 		$19K Sell
1,061
-3,078
-74% -$55.3K ﹤0.01% 972
2020
Q1 		$63K Buy
4,139
+27
+0.7% +$489 ﹤0.01% 758
2019
Q4 		$81K Buy
4,112
+1,554
+61% +$29.7K ﹤0.01% 741
2019
Q3 		$44K Buy
2,558
+131
+5% +$2.27K ﹤0.01% 866
2019
Q2 		$43K Sell
2,427
-760
-24% -$13.8K ﹤0.01% 825
2019
Q1 		$65K Buy
+3,187
New +$64.1K ﹤0.01% 734

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Whittier Trust's TAK Position: Q1 2024 in Review

Whittier Trust sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 70 shares — an estimated $998 sold.

Whittier Trust first reported a position in TAK in Q1 2019 and held it in 20 quarters. The position peaked at $81K in Q4 2019. 314 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

  • Whittier Trust reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Whittier Trust sold 70 Takeda Pharmaceutical shares in Q1 2024, an estimated $998.
  • Whittier Trust first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 20 quarters.
  • Whittier Trust's Takeda Pharmaceutical position peaked at $81K in Q4 2019.
  • 314 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Whittier Trust's 13F filing for Q1 2024, filed 2 May 2024.